Skip to main content
OpenTrials
Completed

NCT Number: NCT03410550

Exoskeleton and Spinal Cord Injury

The purpose of the current study is to investigate the effects of powered exoskeleton (EKSO) on cardiovascular performance as measured by resting blood pressure and heart rate, peak oxygen consumption during walking, energy expenditure, whole and regional body composition assessments. The effects of exoskeleton training on walking kinematics including stand-up time, walking time, distance covered and speed of walking will also be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, 23249, United States

About this study

Powered exoskeletons using robotic suits have recently been introduced for the rehabilitation of persons with spinal cord injury (SCI). Exoskeletons offer a unique opportunity for persons with SCI to experience standing and walking at a low metabolic cost. Evidence suggested that exoskeleton assisted walking can decrease spasticity and improve bowel movement. Training may also improve the level of physical activity as well as psychological parameters that are likely to interfere with rehabilitation outcomes. Previous studies reported that a frequency of 2-3 times per week or more for 1-2 hours may be beneficial in the rehabilitation of persons with SCI. Using exoskeletal-assisted walking to improve the level of physical activity may be appealing to persons with SCI.

Exoskeleton training for 12 weeks may enhance energy expenditure, parameters of physical activity and result only on modest effects on both cardiovascular and body composition parameters. In other words, persons with tetraplegia may have greater cardiovascular and body composition adaptations compared to persons with paraplegia. Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10) SCI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A written clearance by the medical doctor .
  • Participants will have to be 1 year post-injury with any level of injury.
  • All participants will be between 18-70 years old, men/women,

Exclusion criteria

  • Participants with body weight greater than 220 lbs
  • Whole body T-scores less than -2.5 standard deviation will result in elimination from the program.
  • Hip width, upper leg length and lower leg length that do not fit in the robotic suit.
  • Previous unhealed fracture in both lower or upper extremities
  • Leg length discrepancy that is unlikely to be managed by having shoe inserts
  • High resting blood pressure greater than 130/80 mmHg
  • Sudden drop in blood pressure by 20 mmHg especially in persons with tetraplegia.
  • Medical conditions prior enrollment similar to cardiovascular disease, uncontrolled type II diabetes mellitus, uncontrolled hypertension, and those on insulin, pressures sores stage 2 or greater, or urinary tract infection or symptoms.
  • Pregnancy

Treatment and study plan

Exoskeleton Training

Device

Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10).

Primary outcomes

  1. Blood Pressure (mmHg)

    Time frame: 12 weeks

    Resting blood pressure and post-exercise blood pressure will be measured every visit.

  2. Walking time (minutes)

    Time frame: 12 weeks

    The robotic unit will measure standing up time, walking time and walking distance for every visit.

  3. Oxygen uptake (l/min)

    Time frame: 12 weeks

    Oxygen uptake will be measured during sitting, standing and walking at the beginning and at the end of the training program.

  4. Body Composition (kg)

    Time frame: 12 weeks

    Body composition using dual energy x-ray absorptiometry anthropometrics' will be measured during sitting, standing and walking at the beginning and at the end of the training program.

Secondary outcomes

  1. Six minute-walk Test (meter)

    Time frame: 12 weeks

    The test will competed at the beginning and at the end of study to measure distance.

  2. Walking Index for Spinal Cord Injury II (WISCI II)

    Time frame: 12 weeks

    The test will competed at the beginning and at the end of study

  3. Electromyography (EMG) activity of 6 muscle groups (mV)

    Time frame: 12 weeks

    The test will competed at the beginning and at the end of study

  4. Mitochondrial health using near infra-red spectroscopy (seconds)

    Time frame: 12 weeks

    The test will competed at the beginning and at the end of study

  5. 10 meter walk Test (m/sec)

    Time frame: 12 weeks

    The test will competed at the beginning and at the end of study to measure speed.

Sponsors and collaborators

Lead sponsor

McGuire Research Institute

Other

Registry information

Official study title

Exoskeleton Training After Spinal Cord Injury

Acronym: EXTra-SCI

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Jan 25, 2018
Registry last updated
Feb 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.